In a case report of a patient with a mutation in the melanocortin 4 receptor (MC4R) who had obesity and hypogonadotropic hypogonadism and was experiencing increasing body weight, sibutramine led to the maintenance of body weight and improved body composition and metabolic abnormalities related to obesity (25). This evidence concerns the gene MC4R and hypogonadotropic hypogonadism.